Home > Insider Trading > Filing (0001209191-17-059474)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610876	Jeffrey Chodakewitz	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp Gmda, Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-11-02	1,796	$91.05	56,220	No	4	M	Direct
Common Stock	Disposition	2017-11-02	400	$143.54	55,820	No	4	S	Direct
Common Stock	Disposition	2017-11-02	1,096	$144.89	54,724	No	4	S	Direct
Common Stock	Disposition	2017-11-02	300	$145.89	54,424	No	4	S	Direct
Common Stock	Acquisiton	2017-11-03	3,594	$109.14	58,018	No	4	M	Direct
Common Stock	Disposition	2017-11-03	3,594	$144.69	54,424	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-11-02	1,796	$0.00	1,796	$91.05
Common Stock	Stock Option (Right to Buy)	Disposition	2017-11-03	3,594	$0.00	3,594	$109.14

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,164		2026-02-01	No	4	M	Direct
17,969		2025-02-02	No	4	M	Direct

Footnotes

Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $143.54 (range $142.98 to $143.81).
Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $144.89 (range $144.48 to $145.18).
Open market sales reported on this line occurred at a weighted average price of $145.89 (range $145.63 to $146.04).
Open market sales reported on this line occurred at a weighted average price of $144.69 (range $144.19 to $144.90).
The option vests in 16 quarterly installments from 2/2/2016.
The option vests in 16 quarterly installments from 2/3/2015.